v3.22.4
Integration and Restructuring Plans (Tables)
12 Months Ended
Dec. 31, 2022
Allergan integration plan  
Restructuring charges  
Summary of charges associated with integration plan The following table summarizes the charges (benefits) associated with the Allergan acquisition integration plan:
Severance and employee benefitsOther integration
year ended December 31 (in millions)202220212020202220212020
Cost of products sold$(4)$$109 $121 $127 $21 
Research and development— — 199 23 102 177 
Selling, general and administrative(4)64 388 403 289 237 
Total charges (benefits)$(8)$69 $696 $547 $518 $435 
Summary of cash activity in the restructuring reserve The following table summarizes the cash activity in the recorded liability associated with the integration plan:
year ended December 31 (in millions)Severance and employee benefitsOther integration
Charges$594 $435 
Payments and other adjustments(227)(415)
Accrued balance as of December 31, 2020367 20 
Charges65 461 
Payments and other adjustments(210)(448)
Accrued balance as of December 31, 2021222 33 
Charges (benefits)(8)385 
Payments and other adjustments(116)(409)
Accrued balance as of December 31, 2022$98 $
Other restructuring  
Restructuring charges  
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for 2022, 2021 and 2020:
(in millions)
Accrued balance as of December 31, 2019$140 
Restructuring charges58 
Payments and other adjustments(108)
Accrued balance as of December 31, 202090 
Restructuring charges54 
Payments and other adjustments(111)
Accrued balance as of December 31, 202133 
Restructuring charges193 
Payments and other adjustments(50)
Accrued balance as of December 31, 2022$176